国际专场一
时间：2023年11月17日
地点：福朋喜来登&万豪宴会厅（津澜）
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 08:30-08:35 |
开幕式致辞
陆伟
天津医科大学肿瘤医院
|
||
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 08:35-08:50 |
ASCO's Role in Global Oncology |
Eric Winer | American Society of Clinical Oncology |
| 08:50-09:05 |
Global Collaboration on Cancer Control in Mongolia |
Tsetsegsaikhan Batmunkh | National Cancer Council of Mongolia |
| 09:05-09:20 |
The role of the Hungarian League Against Cancer as a civil organization in cancer control |
Balázs Rozványi | Hungarian League Against Cancer |
| 09:20-09:35 |
The Role of NGO in Global Cancer Control——CACA's Practice and Contribution |
王瑛 | 中国抗癌协会 |
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 09:35-09:50 |
Neoadjuvant Therapy for Sinonasal Undifferentiated Carcinoma |
Ehab Hanna | MD Anderson Cancer Centre |
| 09:50-10:05 |
Clinicopathological Characteristics, Treatment Patterns, andOutcomes in Patients with Laryngeal Cancer |
Dejan Djokanovic | University of Banja Luka |
| 10:05-10:20 |
CIP2A coordinates phosphosignaling, mitosis, and DNA damage response |
Jukka Kristian Westermarck | 芬兰图尔库大学 |
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 10:20-10:35 |
Strategic Application of Radiotherapy for Hepatocellular Carcinoma in Immunooncology Era |
Jinsil Seong | Yonsei University |
| 10:35-10:50 |
Neoadjuvant Therapy for HCC: Tianjin Experience |
宋天强 | 天津医科大学肿瘤医院 |
| 10:50-11:05 |
The Interplay of Gut Microbiome and Cancer Immunotherapy:Mechanisms and Significance |
Amany Zekry | University of New South Wales (UNSW) |
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 11:05-11:20 |
Modulation of global adipose metabolism inhibits tumor growth — An integrated approach for cancer therapy |
Yihai Cao | Karolinska Institute |
| 11:20-11:35 |
A New T Cell Paradigm to Cure Advanced Tumors |
Yong Lu | Cornell University Houston Methodist Hospital |
| 11:35-11:50 |
Genomic Approaches for Unravelling Genetic Drivers of Breast Cancer Among Kenyan Women |
Francis Wekesa Makokh | Mount Kenya University |
美迪康会务通